|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| C07K 16/46 | |||
| A61K 39/395 | |||
| A61P 27/02 | |||
| C07K 16/28 |
| (11) | Number of the document | 2992012 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14721806.9 |
| Date of filing the European patent application | 2014-04-25 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/058417 |
| Date | 2014-04-25 |
| (87) | Number | WO 2014/177460 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 13165744 | 2013-04-29 | EP | |
| 14151316 | 2014-01-15 | EP |
| (72) |
HARTMANN, Guido, DE
REGULA, Joerg Thomas, DE
RUETH, Matthias, DE
SCHAEFER, Wolfgang, DE
SCHLOTHAUER, Tilman, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE |
| HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE |